FMC downgraded at RBC Capital
RBC Capital analyst Ashish Sabadra maintained a Buy rating on Moody’s (MCO – Research Report) on February 4 and set a price target of $550.00.
RBC Capital Markets adjusted its price target for Amgen (NASDAQ:AMGN) shares, reducing it slightly from $324 to $320, while retaining an Outperform rating on the biotechnology firm's stock. The ...
RBC Capital Mkts has recently raised SAGE Therapeutics Inc (SAGE) stock to Sector Perform rating, as announced on November 21, 2024, according to Finviz. Earlier, on October 10, 2 ...
RBC Capital analyst Ashish Sabadra maintained a Buy rating on S&P Global (SPGI – Research Report) on February 4 and set a price target of ...
RBC Capital Markets shifted its stance on Schroders Plc (LON:SDR:LN) (OTC: SHNWF), elevating the investment management firm's ...
Find insight on TotalEnergies, oil and natural gas futures, and more in the latest Market Talks covering Energy and Utilities ...
J.M. Smucker Co. chief executive Mark Smucker leaned on close advisers when he made the decision to bolster the jelly and ...
Investing.com -- RBC Capital Markets on Monday upgraded Carvana (NYSE:CVNA) shares to Outperform, and lifted the target price to $280 from $270. According to the firm’s analysts, following ...
Find insight on BNP Paribas, UBS, Kasikornbank and more in the latest Market Talks covering Financial Services.
RBC Capital keeps an Outperform rating and $235 price target on Alphabet (GOOGL) after its Q4 results. The quarter keeps the AI Search bear ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback